Investigation of IL-33 serum levels in patients with benign and malignant salivary gland tumors-Reference-Cited by-同舟云学术

Investigation of IL-33 serum levels in patients with benign and malignant salivary gland tumors

Published:2018-08-31 Issue:1 Volume:23 Page:61-65
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Zare Razieh¹,Malekzadeh Mahyar²,Hashemi Mohamad³,Khademi Bijan⁴,Andishe-Tadbir Azadeh⁵

Affiliation:

1. Department of Oral and Maxillofacial Pathology, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran

2. Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran

3. School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran

4. Department of Otolaryngology, Khalili Hospital, Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran

5. Oral and Dental Disease Research Center, Department of Oral and Maxillofacial Pathology, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference20 articles.

1. Salivary gland tumors: A clinicopathologic study of 366 cases in southern Iran;Jaafari-Ashkavandi;Asian Pac J Cancer Prev,2013

2. Interleukin-33 expression indicates a favorable prognosis in malignant salivary gland tumors;Rössle;International Journal of Surgical Pathology,2016

3. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system;Sanada;The Journal of Clinical Investigation,2007

4. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: A novel ‘alarmin’;Moussion;PloS One,2008

5. IL-33/ST2 axis in innate and acquired immunity to tumors;Jovanovic;Oncoimmunology,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological effects of IL-33/ST2 axis on oral diseases: autoimmune diseases and periodontal diseases;International Immunopharmacology;2023-09

2. IL-33 biology in cancer: An update and future perspectives;Cytokine;2022-09

3. Tumor microenvironment in salivary gland carcinomas: An orchestrated state of chaos;Oral Oncology;2022-04

4. Clinical Biomarkers in Otolaryngology—Head and Neck Surgery;Ear, Nose & Throat Journal;2021-10-25